美国 · 股市与财经 · Yahoo Finance

Johnson & Johnson (JNJ) Reports Sustained Phase 3 Skin Clearance For ICOTYDE

来源：Yahoo Finance · 美国 10 小时前

Johnson & Johnson (NYSE: JNJ) reported new Phase 3 results for oral peptide ICOTYDE in plaque psoriasis at the 2026 EADV Congress. The oral IL-23 inhibitor showed sustained skin…

在 Yahoo Finance 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Johnson & Johnson (JNJ) Reports Sustained Phase 3 Skin Clearance For ICOTYDE

推荐阅读

Federal judge calls Flock ‘indiscriminate mass surveillance’

Key deals this week: Onsemi, Mattel, Nebius, Advanced Micro Devices, and more

OpenAI leader who quit says he can do more for safety from outside the company

Iran Is Losing Some of Its Leverage Over the Strait of Hormuz

High mortgage rates are trapping homeowners in place, and making renovations harder to afford

U.S. debt is increasingly at the mercy of the market as interest costs surge while elections add more risk to the debt ceiling, ratings agency warns

Johnson & Johnson (JNJ) Reports Sustained Phase 3 Skin Clearance For ICOTYDE

分享

推荐阅读

Federal judge calls Flock ‘indiscriminate mass surveillance’

Key deals this week: Onsemi, Mattel, Nebius, Advanced Micro Devices, and more

OpenAI leader who quit says he can do more for safety from outside the company

Iran Is Losing Some of Its Leverage Over the Strait of Hormuz

High mortgage rates are trapping homeowners in place, and making renovations harder to afford

U.S. debt is increasingly at the mercy of the market as interest costs surge while elections add more risk to the debt ceiling, ratings agency warns